2019
DOI: 10.1007/s00018-019-03235-w
|View full text |Cite
|
Sign up to set email alerts
|

CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in rheumatoid arthritis

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

4
81
1
1

Year Published

2020
2020
2022
2022

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 81 publications
(87 citation statements)
references
References 31 publications
4
81
1
1
Order By: Relevance
“…Li et al (20) found that arsenic trioxide improves the Treg/Th17 balance by modulating STAT3 in treatment-naïve RA patients. Previous studies have demonstrated that CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in RA (3). In the present study, the Treg/Th17 imbalance was confirmed to exacerbate the inflammatory responses in RA.…”
Section: Discussionsupporting
confidence: 79%
See 1 more Smart Citation
“…Li et al (20) found that arsenic trioxide improves the Treg/Th17 balance by modulating STAT3 in treatment-naïve RA patients. Previous studies have demonstrated that CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in RA (3). In the present study, the Treg/Th17 imbalance was confirmed to exacerbate the inflammatory responses in RA.…”
Section: Discussionsupporting
confidence: 79%
“…Previous studies have demonstrated a higher frequency of interleukin (IL)-17-producing Treg cells in the peripheral blood of RA patients compared with that in healthy subjects (2). Van et al (3) found that CCL21/CCR7 signaling in macrophages promotes joint inflammation and Th17-mediated osteoclast formation in RA. Therefore, the balance between Treg and Th17 cells plays a vital role in the pathogenesis of RA and could be a promising immunomodulatory drug target.…”
Section: Introductionmentioning
confidence: 99%
“…Foamy phagocytes in the lesion center, containing abundant intracellular myelin remnants ( Fig. 1, A–D ), showed a more pronounced immunoreactivity for the inflammatory markers CCR7 ( Van Raemdonck et al, 2019 ), CD32 ( Kigerl et al, 2009 ), and IL-1B compared with foamy phagocytes in the lesion rim that contained less intracellular myelin ( Fig. 2, D–I ).…”
Section: Resultsmentioning
confidence: 99%
“…This infiltration in the synovial tissues is partially attributed to CCL21 and its receptor CCR7, where their blockage led to prevention of the migration. 68 It has been reported that plasma CCL19 level and monocyte CCR7 surface expression were higher in RA patients. 69,70 Likewise, CCL19 and CCL21 were reported to be higher in RA patients in comparison to osteoarthritis individuals.…”
Section: Chemokines In Rheumatoid Arthritismentioning
confidence: 97%
“…71 Moreover, CCL19 and CCL21 stimulated osteoclast migration as well as bone resorption by osteoclasts in an animal model of RA, 71 and CCL21 drives osteoclastogensis in RA through M1 macrophage polarization of Th17 cells as well as neovascularization. 68 CCL25 and its receptor CCR9 were both detected in the RA synovium. CCR9 was reported to be expressed on dendritic cells, macrophages, and fibroblast-like synoviocytes.…”
Section: Chemokines In Rheumatoid Arthritismentioning
confidence: 97%